SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Graystone who wrote (4919)7/16/1998 3:54:00 AM
From: Bill Wexler  Read Replies (2) of 7041
 
I am 100% correct about the Zonagen fraud.

I was 100% correct about Zonagen's phony patents

Zonagen has no patent protection for Vasomax - the patents that Zonagen purchased do not protect Zonagen in any way shape or form. patent #1 doesn't cover oral administration of Phentolamine. patent #2 covers an mixture of inert ingredients. Anyone can make a phentolamine tablet...in fact they're already on the market.

I was 100% correct about Vasomax's ineffectiveness.

Zonagen's last presentation for the AUA cut 40% off the stock price in a matter of days for one simple reason, The clinical trials proved oral phentolamine doesn't help ED. Not a surprise since this has been well understood for years.

I was wrong about the NDA submission

I assumed that Zonagen would continue its campaign of lies and obfuscation. The only way they could do that was by delaying the NDA. Now that the NDA has been filed, it is simply a matter of time before Vasomax is rejected and the stock falls to 2 - 3 a share within minutes. This is exactly why there was a huge selloff after the NDA announcement. So even though I was wrong...I was right!!!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext